Novel inhibitors of breast cancer relevant kinases Brk and HER2

Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition

(2013) Midan Ai et al.   CANCER BIOLOGY & THERAPY

Recent advances in novel targeted therapies for HER2-positive breast cancer

(2012) Conleth G. Murphy et al.   ANTI-CANCER DRUGS

Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitors

(2012) Gregory D. Cuny et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo

(2012) S Miah et al.   Oncogenesis

Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review

(2010) L. S. Rosen et al.   ONCOLOGIST

Brk Protects Breast Cancer Cells from Autophagic Cell Death Induced by Loss of Anchorage

(2009) Amanda J. Harvey et al.   AMERICAN JOURNAL OF PATHOLOGY

Evolving novel anti-HER2 strategies

(2009) Kellie L Jones et al.   LANCET ONCOLOGY